GoNuke -
The argument that risk is what is keeping people away right now does not hold much water.
The stock has been considerably de-risked since the days when it was over $1.
If the level of risk was the main factor, we would not be trading at such a discount vs. when the company had not even entered Phase III yet.
This is still a speculative play and will be until 1) Phase III EPP results are shown to be successful, and 2) the drug is approved by the EMEA.
But whoever says risk is the main thing that is keeping people away at this point doesn't know what they are talking about - not an attack on you but whoever proposed that idea to begin with.
Which explains why I have that poster on ignore.
shareholder corporate action, page-13
-
- There are more pages in this discussion • 16 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CUV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$13.87 |
Change
-0.090(0.64%) |
Mkt cap ! $694.3M | |||
| Open | High | Low | Value | Volume |
| $14.00 | $14.07 | $13.84 | $834.5K | 60.01K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1134 | $13.86 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $13.89 | 127 | 1 |
View Market Depth
| Last trade - 16.10pm 10/10/2024 (20 minute delay) ? |
| CUV (ASX) Chart |